191 related articles for article (PubMed ID: 26818111)
1. Do measurements of inflammatory mediators in blood predict recurrence in patients with bisphosphonate-related osteonecrosis of the jaws?
Mücke T; Jung M; Mitchell DA; Wolff KD; Wagenpfeil S; Stockmann P; Kesting MR; Deppe H
Br J Oral Maxillofac Surg; 2016 Apr; 54(3):286-9. PubMed ID: 26818111
[TBL] [Abstract][Full Text] [Related]
2. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of the jaws--a case report.
Kamoh AK; Ogle O
Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
[TBL] [Abstract][Full Text] [Related]
5. A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?
O'Connell JE; Ikeagwani O; Kearns GJ
Ir J Med Sci; 2012 Jun; 181(2):237-42. PubMed ID: 22223192
[TBL] [Abstract][Full Text] [Related]
6. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
Hokugo A
Clin Calcium; 2012 Jan; 22(1):83-90. PubMed ID: 22201103
[TBL] [Abstract][Full Text] [Related]
7. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
8. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
9. Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws.
Mücke T; Koschinski J; Deppe H; Wagenpfeil S; Pautke C; Mitchell DA; Wolff KD; Hölzle F
J Cancer Res Clin Oncol; 2011 May; 137(5):907-13. PubMed ID: 20927569
[TBL] [Abstract][Full Text] [Related]
10. [Risk assessment of bisphosphonate-related osteonecrosis of the jaw based on CBCT scans].
Koppány F; Joób-Fancsaly Á; Németh Z; Belik AA; Vaszilkó M; Varmuzsa EM; Csomó KB
Orv Hetil; 2020 May; 161(21):867-872. PubMed ID: 32427571
[TBL] [Abstract][Full Text] [Related]
11. The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws.
Mücke T; Koerdt S; Jung M; Mitchell DA; Wolff KD; Kesting MR; Loeffelbein DJ
J Craniomaxillofac Surg; 2016 Apr; 44(4):369-73. PubMed ID: 26857755
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?
Pichardo SE; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):287-92. PubMed ID: 23953415
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
Di Fede O; Fusco V; Matranga D; Solazzo L; Gabriele M; Gaeta GM; Favia G; Sprini D; Peluso F; Colella G; Vescovi P; Campisi G
Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaws.
Kushner GM; Alpert B
Curr Opin Otolaryngol Head Neck Surg; 2011 Aug; 19(4):302-6. PubMed ID: 21677585
[TBL] [Abstract][Full Text] [Related]
15. [Review of bisphosphonate related osteonecrosis of the jaws].
Zhao TT; Zhong Z; Xiao SF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):589-592. PubMed ID: 29871082
[TBL] [Abstract][Full Text] [Related]
16. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-related osteonecrosis of the jaws--a review.
Kühl S; Walter C; Acham S; Pfeffer R; Lambrecht JT
Oral Oncol; 2012 Oct; 48(10):938-947. PubMed ID: 22525606
[TBL] [Abstract][Full Text] [Related]
18. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
[TBL] [Abstract][Full Text] [Related]
19. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
20. Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients.
Veszelyné Kotán E; Bartha-Lieb T; Parisek Z; Meskó A; Vaszilkó M; Hankó B
BMJ Open; 2019 May; 9(5):e025600. PubMed ID: 31122970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]